Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 2 hours 34 min ago

Under Fire From Investors, Walmsley Outlines Vision for GSK

Wed, 06/23/2021 - 02:00
CEO Emma Walmsley’s vision includes a projected $46 billion in annual sales from the stand-alone pharma company by 2031 and more than 10% operating profit over the next five years.

Likely Link between mRNA Vaccines and Rare Cases of Heart Inflammation, CDC Panel Says

Wed, 06/23/2021 - 02:00
Concerns over vaccination links to heart inflammation are valid, a U.S. Centers for Disease Control and Prevention advisory committee announced this afternoon.

FDA Releases Details About Internal Debate Over Biogen’s Aduhelm for Alzheimer’s

Wed, 06/23/2021 - 02:00
The drug was approved on June 7 under the agency’s accelerated approval pathway, despite the agency’s Peripheral and Central Nervous System Drugs Advisory Committee voting against the drug in November 2020 and having been assured at that time the agency was not considering an accelerated approval.

Cuba’s COVID-19 Vaccine is 92% Effective, Late-Stage Trials Show

Tue, 06/22/2021 - 02:00
Cuba’s Abdala vaccine is 92% effective against the novel coronavirus, according to a recent analysis of late-stage trials.

COVID-19 Might Have Long-Term Effects on Sense of Taste and Smell, According to UK Researchers

Tue, 06/22/2021 - 02:00
Recent research shows those who had been hospitalized due to COVID-19 might already have a reduced sense of smell and taste, not just for the short term, but possibly for life.

COVID-19 News: New COVID-19 Vaccine Efficacy, MIS-C and More

Tue, 06/22/2021 - 02:00
Please check out the biopharma industry's COVID-19 stories that are trending for June 22, 2021.

Spruce's Drug Candidate Reduces Elevated Hormones in Classic CAH Patients

Tue, 06/22/2021 - 02:00
Spruce Biosciences shared results from two Phase II studies assessing tildacerfont, a non-steroidal, oral antagonist for the treatment of adult patients with classic CAH.

Hong Kong Biotech Scores $255 Million to Take First AI-Discovered Candidate to Clinic

Tue, 06/22/2021 - 02:00
Founded in 2014, Insilico focuses on using artificial intelligence for drug discovery and development.

Cantex Intends to Repurpose Failed Alzheimer’s Drug for Cancer Indications

Tue, 06/22/2021 - 02:00
Cantex forges a licensing deal with vTv Therapeutics and intends to evaluate the vTv drug as a potential treatment for several cancer-related issues.

SAB Biotherapeutics Combines With Blank Check Company to List on Nasdaq

Tue, 06/22/2021 - 02:00
The business combination agreement will advance SAB’s proprietary platform to develop antibody therapies for immune system disorders and other diseases.

Roche Presents Positive Clinical Data for Neurology Programs at EAN Annual Meeting

Tue, 06/22/2021 - 02:00
Roche presented results from several Phase II and III trials at the 7th Congress of the European Academy of Neurology (EAN) Annual Meeting held virtually June 19-22.

TRexBio Chomps Down on $59 Million Series A for Immunobiology

Tue, 06/22/2021 - 02:00
As part of the announcement, TRexBio indicated that Johnston Erwin had been appointed CEO and Ovid Trifan would be the company’s CMO.

ViiV Signs Licensing Deal for Halozyme's Tech to Create Long-Acting HIV Drugs

Tue, 06/22/2021 - 02:00
​Halozyme revealed that ViiV will pay $40 million upfront for the exclusive license to four small and large molecule targets and then pay the remaining $175 million in milestones.

Allogene Overland Biopharm Taps Cell Therapy Veteran Yao as CEO

Mon, 06/21/2021 - 02:00
Yao has more than 15 years of experience in the cell and gene therapy fields. He also established and directed the Cell Therapy R&D business unit, with a focus on CAR-T development.

Data Supports Use of Anti-Parasitic Drug Ivermectin in COVID-19 Patients, Study Shows

Mon, 06/21/2021 - 02:00
Use of the anti-parasitic drug ivermectin could reduce COVID-19 related deaths, data from a peer-reviewed study shows.

HHS Withdraws Advisory Opinion on 340B Drug Discount Program

Mon, 06/21/2021 - 02:00
This program limits the prices drug manufacturers can charge for therapies sold to specific healthcare facilities, including public hospitals and community health centers.

Report: Activist Investor Signals Call for GSK Leadership Change

Mon, 06/21/2021 - 02:00
GSK CEO Emma Walmsley may face some contentious opposition from key investors interested in forcing a management change following the planned investor update.

Moderna Rapidly Expands COVID-19 Vaccine Plant Production, Adds 155 Jobs

Mon, 06/21/2021 - 02:00
Though the world is reopening, this pandemic is not over. Moderna continues expanding production to answer the call globally.

Neogene Picks Cell Therapy Hub Santa Monica as U.S. Headquarters

Mon, 06/21/2021 - 02:00
The new U.S. HQ for Neogene has the backing of biotech guru Arie Belldegrun, CEO of Kite Pharma. The company has leased 38,000 sq. ft. in two Santa Monica buildings.

FDA Action Alert: Incyte and Ascendis

Mon, 06/21/2021 - 02:00
Incyte had a particularly big week scheduled with the U.S. FDA, which included two PDUFA dates and an advisory committee meeting. In addition, Ascendis had a target action date.